A Prospective, Randomized, Placebo-Controlled Study of a Combination of Simvastatin and Chemotherapy in Metastatic Breast Cancer

Table 2

Efficacy outcomes.

Best response	Chemotherapy + simvastatin (n = 40)	Chemotherapy + placebo (n = 40)	value
	n (%)
Complete response	1 (2.5)	4 (10)	0.57
Partial response	13 (32.5)	9 (22.5)
Stable disease	10 (25)	11 (27.5)
Progressive disease	14 (35)	15 (37.5)
Not evaluable	2 (5)	1 (2.5)

The assessment did not include the withdrawn consent patients (n = 2)